Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "vision"

1308 News Found

Health Secretary addresses workshop on 'Roadmap to Strengthen Public Health Preparedness and Response Capabilities of Points of Entry (PoEs) in India'
Policy | September 08, 2022

Health Secretary addresses workshop on 'Roadmap to Strengthen Public Health Preparedness and Response Capabilities of Points of Entry (PoEs) in India'

India is an example in front of the world to contribute towards strengthening Points of Entry during a public health emergency


President to launch Pradhan Mantri TB Mukt Bharat Abhiyaan on Sept 9
Policy | September 08, 2022

President to launch Pradhan Mantri TB Mukt Bharat Abhiyaan on Sept 9

The virtual event will be attended by representatives from state & district health administration, corporates, industries, civil society, and NGOs as the country reiterates its commitment towards TB elimination by 2025


Healthcare sector is expected to reach US $50 bn by 2025
News | September 08, 2022

Healthcare sector is expected to reach US $50 bn by 2025

Healthcare has become more focused on innovation and technology over the past two years and 80% of healthcare systems are aiming to increase their investment in digital healthcare tools in the coming five years


SIRIO appoints Lonza’s Sara Lesina as General Manager in Europe
People | September 08, 2022

SIRIO appoints Lonza’s Sara Lesina as General Manager in Europe

Her appointment further strengthens the CDMO’s strategy to become the nutraceutical R&D hub for brands looking for agile partners with large scientific and development resources


Mandaviya virtually lays Foundation Stone of NCDC branches in 6 states
Policy | September 07, 2022

Mandaviya virtually lays Foundation Stone of NCDC branches in 6 states

NCDC branches in States/UTs will provide a boost to Public Health Infrastructurewith prompt surveillance, rapid detection and timely monitoring of diseases enabling Early Interventions


Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
interviews | September 05, 2022

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.


AstraZeneca partners with Alveofit to scale up the diagnosis and treatment of lung diseases in India
News | September 05, 2022

AstraZeneca partners with Alveofit to scale up the diagnosis and treatment of lung diseases in India

This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.


Dr. Mandaviya emphasizes on ‘Jan Bhagidari’ to popularise organ donation
News | September 05, 2022

Dr. Mandaviya emphasizes on ‘Jan Bhagidari’ to popularise organ donation

The purpose of the conclave was to discuss the present situation of body-organ-eye donation in India and find solutions to the challenges ahead in future


A 10-year commission with dedicated mission is required to tackle the upsurge of diabetes in India: says Expert
Healthcare | September 01, 2022

A 10-year commission with dedicated mission is required to tackle the upsurge of diabetes in India: says Expert

India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved


Bayer initiates Phase III study program to investigate oral FXIa inhibitor asundexian
Clinical Trials | September 01, 2022

Bayer initiates Phase III study program to investigate oral FXIa inhibitor asundexian

The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke